The I-SPY 2 trial employs a groundbreaking clinical trial model that uses genetic or biological markers (“biomarkers”) from individual patients’ tumors to screen promising new treatments, identifying which treatments are most effective in specific types of patients.
Understanding Targeted Therapies for Cancer is an animated, educational tutorial series developed by the National Cancer Institute for health professionals. The tutorials, available online or in DVD format, provide practitioners with an overview of targeted cancer therapies, the latest FDA-approved targeted therapy drugs, and active clinical trials involving these treatments.
The Avon-NCI Progress for Patients Awards Program, completed in 2009, made a significant impact on breast cancer research, accelerating the movement of pre-clinical discoveries to application in patients, and fostering collaborative efforts that optimized resources and efficiencies.
